论文部分内容阅读
一般认为,静脉给予利多卡因是室性快速心律失常的首选治疗。但如患者已有对利多卡因过敏、利多卡因引起癞痫大发作,或存在高度房室传导阻滞、严重肝功能不全,以及对利多卡因已引起抗药性等情况时,利多卡因常属禁忌可难发挥预期作用。近几年来,镁离子的抗心律失常作用日益被重视。我院自今年6月以来,对9例室性早搏(以下简称室早)住院患者,以硫酸镁静脉注射治疗,报告如下。
Is generally believed that intravenous lidocaine is the preferred treatment of ventricular tachyarrhythmia. However, if the patient has lidocaine allergy, lidocaine-induced epileptic seizures, or a high degree of atrioventricular block, severe liver insufficiency, and lidocaine has caused resistance and so on, the lidocaine Often contraindications can be difficult to play a desired role. In recent years, anti-arrhythmic effects of magnesium ions are increasingly valued. Our hospital since June this year, nine cases of premature ventricular contractions (hereinafter referred to as premature) hospitalized patients, intravenous magnesium sulfate treatment, the report is as follows.